Bank of America has modestly lowered its price target on JD.com, following a similar move by DBS, as analysts revise down revenue and profit estimates for the Chinese e-commerce giant, citing weaker consumer electronics demand and scaled-back subsidy programs.
NetEase Cloud Music has entered a multi-year strategic partnership with Universal Music Group, securing licensing and distribution rights for UMG's vast catalog in China. The deal aims to expand music access for Chinese listeners while creating new global promotion channels for domestic talent.
Chinese tutoring giant TAL Education Group surpassed revenue and profit expectations for its fiscal third quarter, reporting net income of $130.6 million. The results signal a successful strategic pivot following China's sweeping education sector reforms.
Chinese autonomous driving leader WeRide has launched its proprietary general-purpose simulation model, Genesis, designed to bridge the gap between real-world data and virtual testing. The platform promises to drastically cut development time and costs for AV systems, from advanced driver-assistance features to fully autonomous robotaxis.
A sharp, unexpected jump in wholesale prices complicates the White House's economic narrative and its pressure campaign on the Federal Reserve for rate cuts.
Secretary-General Antonio Guterres has issued his starkest warning yet, stating the United Nations' deepening liquidity crisis threatens its operations and risks a financial meltdown, driven by unpaid dues and an antiquated budget rule.
Thousands of Shiite Muslims who fled Syria following the 2024 fall of the Assad government have settled into a newly opened housing compound in northeastern Lebanon, funded by Shiite institutions and Hezbollah, offering a permanent solution after years of temporary shelter.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank has ignited market speculation over the future path of interest rates, with analysts divided on whether his leadership would mean more cuts or a return to hawkish restraint.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
Despite posting a Q4 net loss, Covenant Logistics signals a shift in market dynamics, with executives pointing to rising spot rates, secured contract increases, and a disciplined fleet strategy as precursors to a stronger performance by late 2026.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
While major indices hold steady, a search for growth is turning the spotlight onto smaller companies. We examine three small-cap stocks—from insurance to banking to luxury watches—that are posting strong results and navigating unique challenges in the current market.
Facing rising postpaid churn and prepaid losses, AT&T is aggressively pushing bundled phone and internet packages as its core retention strategy, betting that convergence can stem the tide of subscribers fleeing to rivals and cable companies.
Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
BHP Group achieves a key milestone with full autonomy at its Escondida Norte copper pit, boosting safety and efficiency for its strategic copper expansion. Meanwhile, the miner contends with the commercial impact of China's ongoing ban on iron ore from its Jimblebar operation, forcing a reshuffle of global sales channels.
Carnival Corporation & plc sees its shares rally after posting a record $4.5 billion in operating income for fiscal 2025, reinstating a quarterly dividend, and announcing plans to consolidate its dual-listed structure into a single NYSE entity, signaling a renewed focus on shareholder returns and corporate simplicity.
Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.
The wealth management sector kicks off the year with strategic acquisitions and rebranding moves. Corient expands its Silicon Valley footprint, Carson integrates a long-time partner, and Cetera lures a team from Raymond James, highlighting the ongoing consolidation and competition for advisor talent.
A human rights group has cautioned New York state and city officials that investing public funds in Israeli government bonds may violate international law and fiduciary duties, exposing them to significant legal and financial risks.
